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 1 
A mixed-methods study of challenges experienced by clinical 2 
teams in measuring improvement  3 
 4 
ABSTRACT 5 
Objective: Measurement is an indispensable element of most quality improvement (QI) projects, but 6 
it is undertaken to variable standards. We aimed to characterise challenges faced by clinical teams in 7 
undertaking measurement in the context of a safety QI programme that encouraged local selection 8 
of measures. 9 
Methods: Drawing on an independent evaluation of a multi-site improvement programme (Safer 10 
Clinical Systems), we combined a qualitative study of participating teams’ experiences and 11 
perceptions of measurement with expert review of measurement plans and analysis of data 12 
collected for the programme. Multidisciplinary teams of frontline clinicians at nine UK NHS sites took 13 
part across the two phases of the programme between 2011 and 2016. 14 
Results: Developing and implementing a measurement plan against which to assess their 15 
improvement goals was an arduous task for participating sites. The operational definitions of the 16 
measures that they selected were often imprecise or missed important details. Some measures used 17 
by the teams were not logically linked to the improvement actions they implemented.  Regardless of 18 
the specific type of data used (routinely collected or selected ex-novo), the burdensome nature of 19 
data collection was underestimated. Problems also emerged in identifying and using suitable 20 
analytical approaches. 21 
Conclusion: Measurement is a highly technical task requiring a degree of expertise. Simply leveraging 22 
individual clinicians’ motivation is unlikely to defeat the persistent difficulties experienced by clinical 23 
teams when attempting to measure their improvement efforts. We suggest that more structural 24 
initiatives and broader capability-building programmes should be pursued by the professional 25 
community. Improving access to, and ability to use repositories of validated measures, and 26 
increasing transparency in reporting measurement attempts, is likely to be helpful. 27 
 28 
  29 
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INTRODUCTION 1 
Measurement is essential to improving quality and safety in healthcare processes and outcomes.1 2 2 
Yet the available evidence suggests that many quality improvement projects may fail to generate 3 
reliable or useful data because of challenges in measurement, data collection, and interpretation. 3-6 4 
Characteristic problems include missing data or insufficient data points; insufficient baseline periods; 5 
poorly chosen, unclear, or changing sampling strategies; poorly annotated data; failure to verify data 6 
entry; and poorly chosen or executed analytic strategies.7 8 Benn and colleagues found many of 7 
these problems when teams sought to implement data collection and analysis systems in local 8 
settings as part of a large-scale quality improvement programme.9 Similarly, a study of a national 9 
system for surveillance of healthcare-associated infections10 found variability in how well intensive 10 
care units designed their data collection systems and in how they interpreted data. 11 
Failure to produce reliable data about improvement and to interpret it correctly is an important 12 
challenge for quality improvement, limiting the inferences that can be made about the success or 13 
otherwise of improvement interventions, as well as eroding confidence in the evidence-base for 14 
improvement.11 This problem manifests in summative evaluations but also affects programmes while 15 
they are running, when data has potential to be used formatively to optimise the improvement 16 
effort.  17 
Some of the problems in measuring improvement are likely to be linked to ongoing controversies 18 
about the relevant dimensions of quality and safety and the prioritisation of different types of 19 
measures, including, for example, the process versus outcome debate.8 9 12 Other problems are likely 20 
to be more mundane, relating, for example, to issues in establishing data collection systems.10 21 
Importantly, the literature suggests that some problems may also be linked to ownership: studies of 22 
measurement have tended to focus on quality measures generated externally to clinical teams (e.g. 23 
by regulators or payers), which clinicians may not perceive as directly relevant to their everyday 24 
concerns. One suggestion is  that clinicians may lack engagement because they perceive externally 25 
imposed measures as having little or no relevance to their clinical work and as little more than an 26 
administrative burden.8 Yet little evidence exists on what happens when clinical teams themselves 27 
choose their own measures (rather than having to use those selected externally) and design and 28 
implement data collection systems that they see as fitted to their own local circumstances. A well-29 
characterised account of responses to such an opportunity would be very useful. 30 
In this article, we use data from a mixed-methods independent evaluation of a nine-site UK patient 31 
safety improvement programme to report on clinical teams’ experiences of using locally selected 32 
measures. We aimed specifically to describe their experiences of planning and conducting 33 
measurement activities, collecting data, and analysing and interpreting data for their improvement 34 
projects. 35 
METHODS 36 
The Safer Clinical Systems improvement programme 37 
The study we report is based on data from an independent evaluation of a patient safety 38 
improvement programme run in the UK, which used an approach known as Safer Clinical Systems.7 39 
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Based on methods of risk management and improvement used in other hazardous industries, the 1 
Safer Clinical Systems approach seeks to enable organisations to make improvements to local clinical 2 
systems and pathways using a structured methodology for identifying risks and for modifying or re-3 
engineering systems to control risk and enhance reliability.7 13 It involves a series of steps in which 4 
teams define a clinical pathway and its context; do a detailed diagnostic assessment of the pathway 5 
to identify risks and hazards; assess and select options for change and develop an action plan to 6 
implement them; and undertake system improvement cycles involving implementation, evaluation 7 
of progress against a measurement plan, and revision of interventions. 8 
Measurement is a key element of Safer Clinical Systems. During the course of the programme, 9 
participating teams were expected to: 1) develop a detailed measurement plan to set out outcome 10 
and/or process measures that were appropriate for collecting useful data; 2) establish data 11 
collection systems; and 3) analyse and interpret their data using Statistical Process Control (SPC) 12 
(Box 1).  13 
Box 1 14 
A distinctive feature of Safer Clinical Systems is that it does not try to impose predefined solutions, 15 
but instead seeks to help organisations develop their own capacity to detect and address 16 
weaknesses in their systems, and to measure and report their improvement outcomes. It does so by 17 
offering training on a range of improvement tools and techniques (including how to measure for 18 
improvement), and emphasising the need to engage local staff (clinical and managerial) in 19 
improvement attempts.  20 
Funded by an independent charity (The Health Foundation), the programme was run in a total of 21 
nine UK hospitals in two phases: the main phase, which ran 2011–14 and included eight sites, and 22 
the extension phase, which ran 2014–16 and included six sites (five of the original sites plus an 23 
additional one that had not taken part in the main phase). Each of the nine hospitals taking part in 24 
the programme used the Safer Clinical Systems approach to proactively assess risks and hazards in 25 
their clinical pathways and to develop effective risk-control interventions (Table 1). 26 
In the main programme phase, participating sites received training and guidance, and were 27 
monitored in their progress, by a dedicated programme support team. Support on measurement 28 
included approximately one day of training on principles of measuring improvement, statistical 29 
process control (SPC), and use of software for capturing their data and generating charts. In the 30 
extension phase, teams were expected to use the Safety Clinical Systems approach on their own, 31 
without the support and control that characterised the main phase.  32 
Table 1 33 
Programme evaluation 34 
We undertook an independent evaluation of the Safer Clinical Systems programme using a mixed-35 
method design. We combined a qualitative study, which aimed to describe how participating teams 36 
experienced taking part in the Safer Clinical Systems programme, with expert review of 37 
measurement plans and analysis of data collected for the programme. The study was granted ethical 38 
approval by the [name omitted] Research Ethics Committee [number reference omitted].  39 
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Qualitative study 1 
We conducted semi-structured interviews with members of the participating teams and 2 
unstructured ethnographic observations of teams’ activities related to programme participation. 3 
Particular effort went into capturing how teams undertook tasks relating to measurement (e.g. 4 
identified and selected their quality measures, and developed and implemented a measurement 5 
plan to assess the impact of their improvements). We were also interested in characterising the 6 
challenges and hurdles faced by the teams in doing so.  7 
Observations and interviews were conducted by non-clinical researchers who were members of the 8 
evaluation team. Interviews were conducted in person or on the phone, were recorded digitally, and 9 
transcribed verbatim. All interviewees signed an informed consent form. Observations were 10 
unstructured and included routine clinical activities, team meetings, and informal chats with 11 
relevant staff. Extensive field notes were taken during visits, and researchers were then debriefed by 12 
other members of the evaluation team on return from visits.  13 
Expert review of measurement plans 14 
All the measurement plans prepared by the participating teams were reviewed by one author (XX), 15 
who is a specialist in measurement for improvement and an expert in SPC. Published checklists 16 
aimed at improving the quality of measurement were used as review criteria.3 14  The level of 17 
information on each step of the measurement process provided by teams was deemed unclear if it 18 
was not sufficient for author XX to know how to repeat the measurement process. The reviews of 19 
these plans were used for evaluation purposes (e.g. to assess the quality of the plans) and to provide 20 
formative feedback to the participating teams. This feedback was provided to each team through ad 21 
hoc coaching sessions, led by author XX and the programme support team in the main phase, and 22 
author XX alone in the extension phase. Up to two such sessions, conducted by telephone, were 23 
offered to each team. 24 
Towards the end of each phase of the programme, XX reviewed and independently analysed the raw 25 
data from a selection of the participating sites (four sites in the main phase and four sites in the 26 
extension phase). We initially sought to select sites that would ensure the greatest diversity of 27 
projects. However, some sites did not produce data, or did not produce data in a form suitable for 28 
analysis, and could not be included. Table 1 illustrated the four sites in each phase that had their raw 29 
data subject to independent SPC analysis.  30 
Data analysis and synthesis 31 
Analysis of the qualitative data was based on the constant comparative method, inductively 32 
generating thematic categories, and using the literature on measurement and quality improvement 33 
as sensitising concepts.15 We first analysed data site-by-site to ensure that it was understood in 34 
terms of relevant context. Then, for each site, we integrated qualitative data and findings from the 35 
expert review to produce a comprehensive and in-depth picture of sites’ experiences of 36 
measurement. Finally, we conducted cross-site analysis in order to develop higher-level concepts 37 
and broader learning on measurement.  38 
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RESULTS 1 
Across the two phases of the study (main and extension), the qualitative evaluation study involved 2 
862 hours of observation and 143 interviews (Table 2) covering all aspects of the programme (not 3 
just measurement). The participating site teams specified, between them, a total of 67 measures 4 
that they planned to use to monitor their processes before and after introduction of their risk-5 
control interventions. The data for 49 of these measures – which were sourced from four of the 6 
eight sites participating in the main phase, and from four of the six sites participating in the 7 
extension phase – were independently analysed by the evaluation team (Table 2).  8 
Table 2 9 
The clinical teams participating in the programme typically comprised a clinical lead (often a senior 10 
physician), a project manager, others from a clinical or managerial background, and an executive 11 
sponsor (a senior individual who reported to the board but was not involved in day-to-day running 12 
of the project). The participating sites varied in the extent to which they enjoyed active support from 13 
executive or non-executive board members, and from other clinicians; the interaction of the work 14 
with infrastructure such as large IT system projects; a pre-existing audit culture and organisational 15 
capability for managing complex data; and the resources available to the teams, including release of 16 
staff to undertake project work. In the account below, we offer an analysis of measurement-specific 17 
issues, and specifically on teams’ ability to: 1) manage the tasks associated with developing 18 
measurement plans; 2) establish and use reliable data collection systems; and 3) analyse and report 19 
data in appropriate ways. Our analysis is focused on drawing out generalisable learning across the 20 
programme, and does not seek to compare/contrast sites. 21 
Developing a detailed measurement plan 22 
The measurement plans that the teams were asked to develop were intended to identify and define 23 
suitable measures in advance of any improvement interventions being implemented, and to specify 24 
a sampling and analytical strategy. In the main phase (in which participating teams received 25 
dedicated measurement support and guidance) all teams produced a measurement plan document; 26 
in the extension phase, two out of the six teams did so. When no measurement plan was available, 27 
the evaluation team assessed any written material provided by the teams that included elements of 28 
measurement planning. Our review of the measurement plans (or related documents) indicated that 29 
most demonstrated great enthusiasm but also multiple problems – here, we describe six.  30 
The first problem was the over-ambitious nature of the plans. Several teams initially identified very 31 
many measures (up to 15 in some cases) that were highly diverse in character. Given the formative 32 
nature of the evaluation, these sites were asked to reduce the number of measures in their final 33 
measurement plans to five or six, and to concentrate their efforts on those (Table 1 reports the final 34 
number of measures used by each team after feedback). 35 
Second, many plans did not demonstrate the level of specification or understanding of the 36 
underlying methodological principles necessary to gather good quality data, consistent with varying 37 
confidence about measurement expressed in interviews.  38 
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I am very confident actually, very confident our data is accurate, given the sort of work we 1 
did around some of the reliability and the training. (Interview, main phase of the programme) 2 
The measures are the bit that we're struggling with the most at the moment, using the 3 
BaseLine software I'm not finding easy at all, I'm struggling with it…. I don't feel that I've had 4 
enough training in it. (Interview, main phase of the programme) 5 
Every measurement plan contained examples of operation definitions of measures that were 6 
imprecise, lacked important details, or were difficult to understand by those outside the project 7 
team. For example, some sites used compliance with a care bundle (e.g. medication reconciliation or 8 
review) as a measure, but did not always specify the operational definition of the individual 9 
components of the bundle. One team used a measure labelled as “Number of patients […] who have 10 
their medicines 100% correct at 24 hours” without specifying how staff should ascertain that 11 
medicines were correct. Similarly, terms such as “delay”, “error”, “time zero”, and “baseline” were 12 
not fully defined, leaving room for different interpretations between observers and over time. When 13 
sites reported that some data were “not applicable” to certain measures, they did not always give a 14 
reason for this. 15 
Different names are used to refer to the same measures in this document when compared 16 
with the others, and also in different parts of the same document. For example, the following 17 
two measure names seem to be used interchangeably: “% of patients on EAU [emergency 18 
assessment unit] who have all their medicines correct at 24 hours” and “Accuracy of 19 
prescription at 24h on EAU”. (Evaluation team’s review of the measurement plan, extension 20 
phase) 21 
The third problem was that some measures selected by the teams were insufficiently sensitive to 22 
capture the spectrum of improvements sought by the sites. For example, one site’s definition of 23 
compliance with its medication reconciliation bundle stated that all ten elements of care in the 24 
bundle should be in place. Even if nine elements of the bundle were in place and one was not, the 25 
patient’s care was deemed non-compliant. Bundles should usually include fewer elements (three to 26 
five),16 17 suggesting perhaps suboptimal design of the bundle, but also indicating that full 27 
compliance was unrealistic and that use of this measure might fail to detect potential 28 
improvements.  29 
Fourth, specification of sampling procedures was typically weak, and it was often unclear what 30 
procedure was to be used for random selection. Inclusion and exclusion criteria necessary for 31 
determining who or what should be counted were often unclear. For instance, one site in the 32 
extension phase reported in their measurement plan that “each week a random sample of 5 patient 33 
case notes should be selected for admission, transfer and discharge”, without specifying how such 34 
random sampling should be done. If, for example, staff selected patients randomly from physical 35 
stacks of notes, bias might be introduced if some patients’ notes were unavailable. 36 
The fifth problem was that some selected measures were not logically linked to the improvement 37 
actions they implemented. For example, one site opted to measure the average proportion of 38 
patients going to the operating theatre with a completed perioperative care plan, but then struggled 39 
to implement an intervention that would increase completion of the plans. In this site, due to 40 
uncertainty about the renewal of the hospital IT contract, it was difficult to make available 41 
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documents relevant to surgery on the trust’s IT system at the operation stage, and this improvement 1 
action was therefore abandoned. Thus, although the site recorded an improvement between the 2 
two measurement periods (from 65% to 78% of patients with a complete plan), it was difficult to 3 
attribute the site’s improvement to its Safer Clinical Systems project. 4 
Sixth, in general the measurement plans produced by the teams did not look sufficiently far ahead. 5 
For example, the plans did not contain the specifics of how the data would be analysed, thus 6 
impacting on important considerations such as the appropriate length of the baseline and how much 7 
data over what period would be needed to establish whether an improvement had been made. 8 
Most plans did not touch on who was responsible for taking action for improvement based on the 9 
findings of the analysis, or on embedding measurement in routine care. 10 
Collecting data 11 
Interviews and observations showed that teams generally struggled to set up and run data collection 12 
systems, and that running the systems consumed a huge amount of time and resource at several 13 
sites. Some challenges were related to teams’ decisions to use entirely new measures for the first 14 
time (including “home-grown” measures). Some teams started by using lengthy, unwieldy manual 15 
data collection forms that were sometimes amended or abandoned after a short time. In other 16 
cases, teams used routinely collected data, but these data were often not as clean or well set up as 17 
originally anticipated, and often required extensive effort to bring them up to a standard suitable for 18 
use. 19 
It’s been a nightmare actually… We’ve been looking...at readmissions, and in retrospect I 20 
don’t think the organisation had a consistent metric for readmissions, in terms of what it 21 
meant and how they were collecting it. A lot of people that were being classified as 22 
readmissions weren’t being readmitted, a lot of people were double-counted or triple-23 
counted or worse, and of course then we had really untidy data… (Interview, main phase) 24 
I had to write a database with the coders, had to pay…the data people to give us the feed of 25 
the patients going to [operating rooms]. [This] took a huge amount of time and it meant that 26 
until February I was manually having to get that data from systems which was an absolute 27 
nightmare. But it's better now. (Interview, main phase) 28 
Data collection often depended on voluntary, unpaid or extra activity that was unsustainable. 29 
It certainly has been extra work for all of us, for example observing the handover is not 30 
something that would normally be part of my day-to-day job. But obviously it has been a time 31 
investment. We have used the Health Foundation money to pay for part of it, but there 32 
certainly has been extra goodwill from people who collected the data. (Interview, main 33 
phase)  34 
Data collection systems were not always run exactly as designed, sometimes resulting in missing 35 
data. One team struggled to get reliable data collection at weekends. In one site, a special form that 36 
was supposed to be used for data collection was not consistently used, with data instead collected in 37 
a notebook or on odd pieces of paper in non-standard formats. In another example, attempts to 38 
collect data from doctors at the end of night shifts was met with difficulty, as the physicians were 39 
tired and wanted to finish their clinical tasks before going off duty.  40 
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A further challenge was that teams did not reliably collect baseline data before they introduced 1 
interventions aimed at improvement. In part, this was because once the participating sites became 2 
aware of the many (and, in some cases, severe) hazards threatening patient safety in their clinical 3 
systems through use of the Safer Clinical Systems diagnostic tools, they were understandably eager 4 
to address these hazards quickly. Accordingly, some sites proceeded to implement improvement 5 
actions before measurement had started. The consequent absence of a baseline period, while well-6 
justified in terms of addressing risk, meant that it was difficult to demonstrate that any 7 
improvement was attributable to the programme or indeed that the risk was now well-controlled. 8 
Analysing and interpreting data 9 
The teams’ ability to conduct SPC analysis to present and interpret their data was highly variable. 10 
Some sites succeeded in analysing data on their key process measures regularly and producing high 11 
quality reports. For example, one site recorded changes in clerked weekday in-hours and out-of-12 
hours admissions or senior reviews within four hours of admission; another site analysed the 13 
percentage of patients who had the correct medications at 24 hours after admission. These analyses 14 
were undertaken to a high level of competence and accuracy. Other sites, however, struggled with 15 
undertaking appropriate analysis of their data.  16 
One reason for these differences lay in the variable mix of skills and experience in participating 17 
teams. One team included an academic advisor who had expertise in measurement and experience 18 
working with the hospital’s Quality Improvement Directorate. Other sites lacked such a skillset: 19 
It would have been great to have someone with data analysis skills, or someone from our 20 
informatics team who was dedicated to [our project]. We've used up a lot of our teams' time 21 
learning where different bits are kept. (Interview, main phase)  22 
In some cases, appropriate analysis was not possible because of basic weaknesses in the measures 23 
or data recording, for example, when the definitions used were so poorly specified that it was not 24 
clear exactly what was being measured. For instance, in measuring the time from admission to the 25 
diagnostic test being done, one team recorded the time but not the date of the test. It was therefore 26 
impossible to distinguish whether the test had taken, for example, four or 28 hours. 27 
Analysis was also severely hindered by missing data. For example, in one site, missing data for one 28 
week meant that it was not possible to complete SPC analysis of one of their key measures. This 29 
site’s measurement planning did not include any strategies for minimising or mitigating missing data, 30 
a common theme across the sites. In another site, data collection was frustrated by the small 31 
number of patients meeting the eligibility criteria, complicating any attempts to make valid 32 
inferences or draw conclusions about the impact of the intervention. Since very few measurement 33 
plans included an advance plan for the type of analysis, many sites failed to exploit some available 34 
support tools that would have proved highly beneficial. For example, when using a p-chart,18 tables 35 
could be used to identify an appropriate frequency of data collection and a subgrouping strategy (i.e. 36 
weekly percentages versus monthly or other period) to make sure that the chart is sensitive enough 37 
to be useful.19  38 
Analysis and interpretation were sometimes flawed: we saw evidence of sites assuming that their 39 
data provided evidence of improvement, but such interpretations were not always backed up by 40 
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sound statistical analysis. One site reported improvement on a measure from around 75% to just 1 
under 90%, but no statistical analysis was presented to back up this claim. Visual inspection of a time 2 
series chart seemed to show a potentially unstable process; it was therefore impossible to draw 3 
accurate conclusions from such statements. Another site presented data for two measures that 4 
showed possible evidence of improvement, but without statistical process control analysis it was not 5 
possible to conclude whether this was true improvement in the process.  6 
DISCUSSION  7 
Our study suggests that improvement programmes that emphasise local ownership and local 8 
selection of measures, such as Safer Clinical Systems, may not escape the pervasive challenges of 9 
high quality measurement.  Teams may struggle to produce a high quality measurement plan, to 10 
provide clear definitions of their measures and data, or to complete data collection and analysis 11 
reliably. Participating teams often selected unreliable or inappropriate measures, some of them 12 
“home-grown”, indicating that an emphasis on local ownership of measures is not always 13 
compatible with the need to use the kind of validated measures that are most suited to producing 14 
sound, credible evidence.  The range of skills required to collect and analyse data was not generally 15 
sufficient in most teams, despite some training being provided by the programme. These challenges 16 
were pervasive across sites irrespective of the specific data, measures, and analytical approach 17 
adopted – to the point that they may indicate a systemic problem.7  18 
We did not aim to explain differences across sites, nor to identify the contextual factors promoting 19 
or inhibiting effective measurement in each setting, but our analysis does allow insight into 20 
widespread challenges that may hamper teams’ measurement efforts. The effective execution of 21 
measurement across the lifespan of a quality improvement initiative requires expertise in a range of 22 
technical activities: selecting measures, high fidelity data collection, statistical analysis, and 23 
interpretation of results. The consequences of decisions made in the early stages of designing 24 
measures may not become apparent until the middle or end of an improvement initiative, by which 25 
time it may be too late to secure high quality data. Experience of working on several improvement 26 
initiatives provides valuable insights into the constraints of data access and collection in healthcare 27 
systems, and enables more realistic planning for future initiatives. This study highlights the tendency 28 
for teams without such knowledge and experience to underestimate the challenges they may face in 29 
enacting their measurement plans, and the resulting mismatch in skills and time dedicated to 30 
measurement activities. All of this indicates the need for clinical teams to access dedicated capability 31 
and capacity for measurement. The optimal approach to building or sourcing this capability and 32 
capacity across local and national health systems is not clear, and it seems likely this will take 33 
considerable time to achieve.20 Our study does suggest that it is not realistic to assume that brief 34 
training interventions and manuals will be enough to bring most clinical teams fully up to speed.  35 
As well as measurement-specific issues, broader characteristics of the organisational setting, well 36 
established in the literature as influencers of success in improvement, played a role in enabling or 37 
hindering the teams’ ability to measure effectively.21-23 This complexity means that narrow 38 
interventions are unlikely to be sufficient to improve the quality of measurement in quality 39 
improvement.  Some relatively simple forms of support might, however, be helpful. Existing 40 
repositories of validated measures, such as the US-based AHRQ Measures Clearing House, are 41 
important resources that may not be having their desired impact; teams in this study did not 42 
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reference such repositories in their plans. This may be due to a lack of awareness that such 1 
repositories exist, limitations in the coverage and relevance of repositories for specific improvement 2 
initiatives, and deficits in technical skills and knowledge needed to use centrally constructed 3 
measure definitions. Further research is needed to understand these issues, and to support 4 
healthcare professionals to capitalise on existing resources.   5 
Improving access, and ability to use, repositories of validated measures could go some way to 6 
addressing some of the challenges we identify. Increasing transparency in reporting (e.g. publishing 7 
failed measurement attempts and inappropriate endpoints) might serve the same purpose while 8 
enhancing the evidence base for measurement. Yet, such actions are likely to have limited impact 9 
without a broader programme of measurement capability-building at a system level. The definitions 10 
of measures will always need to be interpreted and implemented in local systems to account for 11 
variation in processes across settings.10 Increased capability in measurement is necessary for staff at 12 
all levels to understand and act in response to measures.  13 
Our study of measurement does have limitations. Although we used established techniques (e.g. 14 
integrating multiple sources of data and collecting data at multiple points in time) to improve the 15 
rigour and generalisability of our analysis, our study is limited the fact that we have examined a 16 
specific improvement programme, which took place in hospitals only and was focused on the 17 
identification of risks in clinical systems.  18 
The potential benefits of robust measurement in improvement initiatives are clear. Yet it is not clear 19 
how best to realise those benefits in practice. Countering the problems of measurement that hinder 20 
quality improvement projects is vital, not least because they undermine the credibility of the 21 
enterprise and diminish the prospect that clinicians will take the results seriously in future 22 
improvement efforts. Unfortunately, using a local ownership approach does not seem to provide an 23 
escape from these problems. We conclude that, in driving improvement, the data (and the data 24 
source) need to be seen as credible by potential participants, while at the same time not too irksome 25 
or burdensome to collect,8 but how to achieve an optimal balance between expert input and local 26 
ownership requires further examination. Future research should focus on understanding how 27 
measurement can be planned, executed, and drawn on to best support improvement in quality of 28 
care for patients. Different models for measurement, aiming to address the challenges highlighted in 29 
this study, should be evaluated. Such models could include those that involve more extensive 30 
training of NHS personnel, loaning of information analysts to improvement teams, resources to 31 
support better planning and execution of measurement, and provision of consultancy expertise.  32 
 33 
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Box 1: Measurement in the Safer Clinical Systems approach 1 
Measurement is a key element of the Safer Clinical Systems approach, which emphasises local ownership and local 
selection of measures for the monitoring of improvement. The approach does not recommend or impose any external 
measures, though it does recommend that Statistical Process Control (SPC) be used as a means of monitoring and 
analysis of data.  
SPC is an approach to understanding and acting on variation observed in measured properties of a system. In this 
approach, data is used to gain insight into how a healthcare system or process is performing, and how this 
performance is changing over time. These insights inform actions on the system, targeted at causes of poor 
performance. Continuing analysis is used to understand whether these actions have led to improvement. 
Control charts are the main analytical tool used in SPC. A control chart shows a time series of how the measure varies 
over time. The centre line represents typical performance of the process or outcome that the team is seeking to 
improve. Control limits (dotted lines parallel to the centre line) show the degree of variation that is to be expected 
assuming that the process or outcome being measured has not changed. SPC provides sets of rules that are used to 
assess a time series for the presence of special cause variation – evidence that performance has changed. 
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Table 1: Sites involved in each phase of the programme and in independent SPC analysis by the evaluation teams 1 
 Aim of the project Data subject to independent 
SPC analysis by XX 
Key challenges and achievements in measurement 
Main phase Extension phase Main phase Extension 
phase 
Main phase Extension phase 
Loganberry  Improve the 
medication 
management pathway 
for patients with 
Parkinson’s disease 
between primary and 
secondary care. 
Improve the 
recognition and 
treatment of venous 
thromboembolism in 
patients admitted for 
surgery. 
No (data 
was not 
suitable for 
SPC analysis) 
 
Yes, data 
from 6 
measures 
 Six measures reported in safety set (no data was 
available on one of these) 
 SPC analysis does not appear to have been used; simple 
before and after comparisons are reported.  
 The small numbers of patients meeting inclusion criteria 
made it difficult to analyse for change over time for all 
measures.  
 
 Six measures reported in safety set. 
 The team were able to collect data against measures, but no explicit 
baseline period was stated.  
 Operational definitions were ambiguous (e.g. no meaning ascribed 
to “Not Applicable” for some variables).  
 Sampling procedure was described as random but it was not clear 
from what population this was taken nor how this was done. 
Elderberry  Improve prescribing 
accuracy for patients 
with an acute medical 
illness by developing a 
prescribing pathway 
between the 
emergency department 
and the emergency 
admissions unit. 
Improve the accuracy 
of prescriptions in the 
emergency admission 
unit (follow up). 
No (not 
included in 
sample for 
independent 
analysis) 
 
Yes, data 
from 7 
measures 
 Of the five measures in the original safety set, only two 
were reported on at the end of the project. 
 Although this site was not included in the sample for 
independent SPC analysis, the measurement report 
produced by the team indicates that SPC analysis, 
presentation, and interpretation for two measures was 
conducted appropriately. 
 
 Seven measures reported in safety set. 
 No formal measurement plan was developed, but elements of 
measurement planning appeared in other project documents. 
 Unclear how denominator was established for three of these 
measures.  
 Sampling procedures were unclear.  
 Despite this, overall data quality was high with little missing or 
invalid data.  
 The team’s measurement ability seemed to improve over the course 
of the project. 
Beechtree  Improve the handover 
across primary, 
secondary, and tertiary 
care for children with 
complex illnesses. 
Improve the 
recognition of, and 
timely response to, 
sepsis or potential 
sepsis in patients 
admitted to the 
emergency 
department. 
No (not 
included in 
sample for 
independent 
analysis) 
 
 
Yes, data 
from 4 
measures 
 Seven measures reported in safety set. 
 No data was available on two of these measures. 
 Many missing data on two measures, and data on two 
further measures was difficult to interpret due to poor 
quality presentation.  
 
 Four measures reported in safety set. 
 No formal measurement plan was developed. 
 Operational definitions were initially unclear but were clarified later 
in the project.  
 Data quality was poor in places leading to difficulties in 
interpretation. 
Cedartree Improve safety and 
effectiveness of the 
transfer of care 
between daytime and 
out-of-hours clinical 
teams. 
Refine the Safety Case 
approach, explore its 
scalability and its 
potential application to 
a complex pathway (i.e. 
surgery). 
Yes, data 
from 5 
measures 
 
No (no data 
were 
collected)  
 Five measures reported in safety set. 
 The large amount of data collected by this team placed 
considerable strain on resources.  
 The team lacked experience to access and use the 
relevant data and IT systems, and initially struggled 
balancing desired data collection against available staff 
time, leading to some missing data.  
 Operational definitions of some measures were unclear. 
 Only one month of baseline data was available, making it 
hard to evaluate improvement. 
The project stalled after the diagnostic phase. No risk controls were 
implemented and no measurement plan was in place. 
15 
 
Rowanberry  Reduce the number of 
medication prescribing 
errors that reached the 
patient in the acute 
medical unit. 
Improve the reliability 
and accuracy of 
medicines reviews and 
reconciliation on 
admission and 
discharge. 
Yes, data for 
4 measures 
 
 
Yes, data 
from 3 
measures 
and 10 sub-
measures 
 Four measures reported in safety set. 
 The measurement plan evolved over time, as the team 
realised that they were trying to measure too much and 
not were not measuring the right things.  
 Team were able to collect data successfully for their 
revised measures. 
 Three main measures and ten sub-measures reported in the safety 
set. 
 Initially the team planned to record only pre-aggregated total 
figures, rather than patient-level data. Following formative 
feedback, this approach was modified to enable patient-level data 
to be recorded. 
 The team then successfully established a measurement system 
providing data on their safety set measures on a regular basis.  
 Ashtree Improve the quality 
and safety of shared 
care of renal patients 
receiving surgical 
intervention. 
Did not take part in this 
phase 
Yes, data 
from 6 
measures 
 
/  Six measures reported in safety set. 
 Some operational definitions were ambiguous. 
 Due to missing data resulting in small denominators, 
some measures suffered from low sensitivity.  
 Baseline periods not clearly stated.  
 The team were able to conduct control chart analysis 
appropriately for some measures.  
/ 
Hollyberry Reduce medications 
prescription errors and 
increase the safety of 
the prescribing 
pathway for patients 
admitted to the acute 
medicine admissions 
unit from primary care 
or the emergency 
department. 
Did not take part in this 
phase 
Yes, data 
from 4 
measures 
 
 
/  Four measures reported in safety set. 
 Some ambiguity in the operational definitions used by 
the team (e.g. it was not clear what was meant by a 
“complete” or “satisfactory” drug chart).  
 Missing data led to a lack of sensitivity in some 
measures. 
 However, the team were able to collect a large amount 
of data to ascertain the outcomes of their improvement 
projects. 
/ 
Oaktree Reduce the number of 
unplanned 
readmissions to 
hospital among 
patients aged 75 years 
or older. 
Did not take part in this 
phase 
No (data not 
suitable for 
SPC analysis) 
 
 
/  Three measures reported in safety set. 
 During the early part of the project, the team discovered 
that the way readmission rates were being calculated at 
their organisation had a flaw, and had to undertake a 
data cleaning exercise to resolve this.  
 The methodology used to detect change was never 
clearly described. 
 
Blueberry  Did not take part in this 
phase 
Improve the 
medication 
management process 
(with particular focus 
on sepsis six care-
bundle) and explore 
the possibility to use 
the Safety Case 
approach for assurance 
purposes. 
/ No data 
were 
collected. 
/ The project stalled after the diagnostic phase. No risk controls were 
implemented and no measurement plan was in place. 
1 
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Table 2: Data collected in the evaluation of each phase of the programme 2 
 Qualitative data Quantitative data 
Main phase 668 hours of observations  
94 recorded interviews 
Measurement plans for 8 sites 
Data from 37 measures were available for independent SPC 
analysis, 19 of which were included (data from 18 measures were 
not amenable to independent analysis) 
Extension 
phase 
194 hours of observations  
49 recorded interviews 
Measurement plans for 6 sites 
Data from 30 measures were included in independent SPC analysis 
Total 862 hours of observations 
143 recorded interviews 
Data from 67 measures, 49 of which were included in 
independent SPC analysis 
 3 
 4 
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